Metraipolis › archive › dc_46a0de9dbdee

The orally available SIK2/SIK3 inhibitor SK-124 increases bone mass in hypogonadal male mice — Europe PMC PMID:41908158

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41908158
DOI
10.1093/jbmrpl/ziag032
License (as archived)
solo-consultazione
Archived
2026-11-05T02:16:53.015Z
SHA-256 of the archived text
7b54ffc965b7c46dd48034092d57971d38828e50e96af4226a3c6e53305456db
Stable URL of this page
https://metraipolis.com/documento/dc_46a0de9dbdee

How to cite

The orally available SIK2/SIK3 inhibitor SK-124 increases bone mass in hypogonadal male mice — Europe PMC PMID:41908158 — Europe PMC (en), https://europepmc.org/article/MED/41908158 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_46a0de9dbdee (Metraipolis archive dc_46a0de9dbdee, sha256 7b54ffc965b7c46dd48034092d57971d38828e50e96af4226a3c6e53305456db)
BibTeX
@misc{dc46a0de9dbdee,
  title = {The orally available SIK2/SIK3 inhibitor SK-124 increases bone mass in hypogonadal male mice — Europe PMC PMID:41908158},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41908158},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_46a0de9dbdee; sha256 7b54ffc965b7c46dd48034092d57971d38828e50e96af4226a3c6e53305456db},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41908158. Agents can read the archived copy with the MCP tool read_document.